Industry News
List of FDA Approved PEGylated Drugs Up t…
History of PEGylated drugs, list of FDA approved PEGylated drugs, advantages and challenges of PEGylation.
Dual/Triple-Agonists Targeting GLP-1R
The success of tirzepatide has made GLP-1 dual/triple agonists a hot area of competition.
New Advances of Antibody-Drug Conjugates …
Among the many ADCs in development, several companies are actively seeking unique breakthroughs to stand out. Lets explore these companies innovative approaches.
Lipid Nanoparticles: Revolutionizing Gene…
Gene therapy, a future star in medicine, is rapidly transitioning from theory to practice. Lipid nanoparticles (LNP), as an innovative delivery system, have brought revolutionary breakthrough…
FDA Approved Treatments for Geographic At…
Pegcetacoplan (Syfovre) and Avacincaptad pegol (Izervay) are currently the only approved treatments for GA, but there is still room for improvement in their efficacy.
Application of PEG Derivatives in ADC Lin…
PEG Linker is one of the most widely used linkers in ADCs, which can increase the water solubility, improve the DAR value and increase the cycle half-life of ADCs.
The Rise of siRNA Drugs in Modern Therape…
To date, the FDA has approved six siRNA drugs，only Patisiran uses a lipid nanoparticle (LNP) delivery system, while the others use the GalNAc delivery system
Re-Engineering IL-2 For Immuno-Oncology A…
IL-2 can be applied in both the field of anti-tumor therapy and the field of autoimmune disease treatment.
PEG Derivatives for Long Acting rhG-CSF
G-CSFs have become the major therapeutic option for the treatment of patients with neutropenia.
Peptide-Drug Conjugates Approvals and In …
Currently, there are only two PDCs approved for therapeutic use globally and 40+ PDCs in clinical trails.
sales@huatengusa.com
+86 0731 89916275